The concept of elicitation of reactions of anaphylactic type by non-tissue-fixing antibody, through activation of complement and release of anaphylatoxins by antigen-antibody complexes in vivo, is not clearly defined by published evidence. Experimental data are presented to demonstrate that guinea pig immunoglobulin G2 (noncytotropic) complexed with antigen in vitro elicits dermal reactions in guinea pigs, and that pretreatment of animals with complement-inactivating cobra venom factor diminishes such reactions. The various pathways through which immediate hypersensitive reactions may occur are discussed.
Previous reports from this laboratory have indicated that anaphylactic reactions in the guinea pig (passive cutaneous anaphylaxis [PCA], release of histamine [H] from lung in vitro) can occur outside the rigid requirement that cell-bound antibody must react with antigen in ratios that include at least two molecules of antibody for each molecule of antigen, the "bridging" effect (19) . In our experience, such reactions can occur with certain monovalent antigens (e 2,4-dinitrophenyl [DNP] a-substituted lysine; various arsanilic acid compounds) that permit combinations of antigen with antibody only in the restricted range of 1:1 or 2:1 (2, 9, 14, 30, 31) . Some populations of cytotropic antibody may be particularly adept in participating in such reactions with monovalent antigens (31; L. T. Rosenberg and A. Amkraut, Fed. Proc. 31:758, 1972) .
Another pathway for the occurrence of anaphylactic reactions may be through the activation of complement by antigen-antibody complexes in which the antibody is not cytotropic but is complement activating. There is an historical basis for believing that this should be the case, beginning with the descriptions by Friedemann (11) and Friedberger (10) of "anaphylatoxin" produced in vitro by incubation of antigen-antibody precipitate in normal serum. This notion has been revived more recently in reports (29) that anaphylatoxins are split from activated complement (C3 and C5) by complexed antigen-antibody. It is also possible that the kinin cascade may be triggered by complement-activating complexes (21) .
The evidence for a role of anaphylatoxins in vivo is mixed. A report in 1957 (12) indicated that preformed antigen-antibody complexes ' (12) noted that, although preformed complexes in antibody excess fix complement, they are poorly anaphylactogenic. Further, Christian (6) found that aggregated human gamma globulin injected into guinea pigs reduced their complement levels markedly but occasioned only a few mild anaphylactic reactions. These various experiments were carried out before the existence of antibody classes was clearly appreciated, and the results can be interpreted in different ways by retrospectively assigning properties of various antibody classes to the antisera used.
Experiments carried out during the current era of cognizance of the biological properties of immunoglobulin classes are more directly interpretable. Izhizaka (15, 16) says that skin-reactive complexes for guinea pigs are made only by antibody having skin-sensitizing activity, and that, whereas aggregated human yG produces reactions in guinea pigs (this is both cytotropic and complement fixing), aggregated human 'yM (which is complement fixing but not cytotropic) fails to do so (18) . In a few guinea pigs, Kay and Austen (22) found immunoglobulin (Ig) G2 preformed complexes to be as effective in eliciting dermal reactions as complexes made with IgGl, but all reactions reported were small (3 to 6 mm in diameter). Depletion of complement with cobra venom factor (CoF) did not alter these results. Broder (I. Broder, Fed. Proc. 28:377, 1969) found that preformed guinea pig IgG2-antigen complexes released histamine from guinea pig lung preparations, although this globulin did not sensitize animals for PCA. volume of saline and dialyzed at 4 C against saline. The crude globulin solution was then centrifuged to remove insoluble material and was concentrated using a PM-10 Amicon filter.
Gamma-1 and gamma-2 globulins were separated on diethylaminoethyl-cellulose columns (35) . Gamma-2 was eluted with 0.005 M phosphate buffer, pH 8. The effluent was collected until the gamma-2 peak returned to baseline as monitored with an on-line ultraviolet recorder. The buffer was then changed to 0.15 M phosphate, pH 8, and gamma-1 was eluted.
After concentrating the gamma-1 and gamma-2 Ig solutions to about one-tenth the original serum volumes, they were tested for antibody reactivity against DNPl2-BSA in Rheophoresis agar double-diffusion plates (Abbott). Both Ig's showed bands of precipitation.
The globulin preparations were subjected to immunoelectrophoresis against rabbit anti-guinea pig serum (Immunology, Inc.) and two rabbit anti-guinea pig 7S globulins (Immunology, Inc., and Cappel Labs.). Gamma-2 moved as a single band as visualized with all antisera. Gamma-1 showed three additional bands with the rabbit anti-guinea pig serum, and one additional faint band occurred in the gamma-1 arc with both anti-guniea pig 7S globulins.
Efforts were made to remove these proteins by isoelectric focusing (LKB type 8101 ampholine column) in a pH 5 to 8 gradient. PCA activity was recovered from the eluates in the middle area of the isoelectric gradient (pH 6 to 7). Although one of the non-gamma G bands was removed from the pH 7 fraction, none was removed from the pH 6 fraction. Furthermore, the faint 7S band was not eliminated. No additional attempts were made to purify gamma-1 for these experiments.
PCA. Titrations were performed with both globulin preparations. One-tenth milliliter of twofold dilutions of antibody was injected intradermally into the shaved flanks of 250-g Hartley guinea pigs. Three to 4 h later, antigen plus dye (50 Ag of DNP,2-BSA in 0.5 ml of 1% Evans blue) was injected intravenously into nonanesthetized animals. The skin reactions were measured and recorded at 5-min intervals for 60 min.
The PCA titer (the dilution required to produce a reaction of 5 Quantification of anti-DNP antibody in gamma-1 and gamma-2 globulins. Quantities of antibody in the globulin preparations were determined by passing '251-labeled aliquots through an antigencontaining column and relating the proportion of counts in the bound protein to the total count of each globulin preparation ot' known protein concentration. Procedures were as follows.
(i) Labeling of gamma-l and gamma-2 with 1251 (I*). The globulin preparations to be labeled were centrifuged at 9,000 x g for 30 min at 4 C to remove any insoluble material. Normal gamma-1 and gamma-2 were labeled by a modification of the lactoperoxidase method described by Marchalonis (27) 
COMPLEMENT-DEPENDENT ANAPHYLACTIC REACTIONS
To monitor the combining ability of the gamma-2 antibody preparation used, sucrose density gradient determinations were run with mixtures of antigenantibody at ratios of 5.2:1 and 1:1. For this purpose, I*-labeled DNP,2-BSA (1.1 x 105 counts/min per jg of protein) was mixed with antibody; the mixtures were applied to a 5 to 20% sucrose gradient medium along with catalase as a marker (molecular weight, 250,000; 11.3S). Total protein in each effluent tube was determined by the Lowry procedure (23) . As control, the radioactive antigen was mixed with a preparation of normal gamma-2 globulin.
Radioactive peaks in the region of sedimentation constants greater than that of the catalase marker were considered to represent complexes. In both cases, the amount of globulin bound to antigen corresponded to the total antibody content of the globulin preparations used, and in both cases a peak of excess unbound antigen was present.
In the 5.2:1 antigen-antibody mixture, 7% of the complexes were composed of antigen-antibody 2:1 and 3:2, 50.7% of complexes of ratios 1:35 to 1.02:1 and 48.6% of complexes of ratios 1:1.5 to 1:2.4.
In the 1:1 antigen-antibody mixture, the populations of complexes were: 0.5:1 to 1:1, 55%; 0.14:1 to 0.31:1, 45%.
Skin tests with complexes. The soluble complexes prepared as described above were tested for their abilities to elicit immediate skin reactions in Hartley guinea pigs. One-tenth milliliter of complex-containing solution was injected intradermally into the shaved flanks of animals of about 250-g weight. The gamma-2 complexes contained 34 zg of antibody mixed with various quantities of antigen per injection (Table 1) (32) . Hemolytic activities of the sera were determined on the basis of 50% hemolysis (20) using four quantities of each serum for each determination, after a preliminary titration to assess the range of quantities to be used. Percentage of residual complement was then calculated directly from quantities of pre-and post-treatment serum required for 50% hemolysis. Hemolytic activity in 20 CoF-treated guinea pigs was reduced by 99% in some instances, but only by 30% of the pretreatment level in others, as calculated from the relative quantities of serum required for 50% hemolysis.
RESULTS
(i) Skin reactions elicited by IgG2-antigen complexes. Guinea pig anti-DNP,7-KLH IgG2 containing 680 Ag/ml was mixed in equal parts with dilutions of DNP,2-BSA so that each 0.1 ml of mixture for injection contained 34 gg of antibody and antigen to provide molar ratios in the mixtures of antigen-antibody from 8:1 to 0.5:1. In Table 1 are recorded 33 reactions in 19 guinea pigs. It is apparent that reactions occurred over a considerable range of mixtures of antigen and antibody. The populations of complexes contained in these mixtures, as judged by the determinations in sucrose density gradient runs (see Materials and Methods), ranged from extreme antigen excess (antigen-antibody, 2:1) to antibody excess (antigen-antibody, 14:1).
This preparation of IgG2 did not induce PCA reactivity even when injected undiluted (68 Mg of antibody protein) intradermally into normal guinea pigs. Hence, contamination with IgGl is discounted as influencing these results.
(ii) Effect of reducing complement levels on IgG2 complex reactions. CoF was injected into guinea pigs to diminish complement levels according to the procedure of Cochrane et al. (7) , as described in Materials and Methods. Within 5 h after the last injection, animals were bled for determinations of hemolytic complement, and skin sites were injected with Ig G2 complexes as well as with antibody and antigen separately in concentrations equivalent to those used in the mixtures. The 33 reactions occurring in these animals are plotted in Table 2 against the average of 33 tests in untreated animals. The "control reaction" line represents the average of the latter reactions for each molar ratio of antigen-antibody complex used.
Of the 33 tests in 25 cobra venom-treated animals, 24 (73%) were smaller than those in the untreated. Of the 33 tests in cobra venomtreated animals, 16 (48%) showed responses of 3 mm or less. In untreated animals six of 33 (18%) showed such reactions. The x2 for these values is 5.52, P < 0.05.
In the animals treated with CoF, complement measured by residual hemolytic activity was never entirely depleted and sometimes was only moderately diminished. Table 3 shows the occurrence of skin reactions in relation to residual VOL. 11, 1975 showed no differences from simultaneously tested controls. In paired experiments in CoFtreated and untreated guinea pigs, using various amounts of antibody for dermal sensitization, the results were as shown in Table 4 . These data confirm other reports (7, 8, 22, 24) .
DISCUSSION
The object of this report is to provide evidence on the question of multiple pathways for the occurrence of immediate hypersensitive reactions. We have previously presented data to the effect that in the guinea pig reactions involving hetero-or homocytotropic antibody can be elicited with certain monovalent antigens; hence, the proposed requirement of bridging of antigens by antibody at the cell membrane is not an inflexible one. Certain populations of cytotropic antibodies are most apt in participating in reactions with monovalent antigens, and this property is distinct from high combining affinity (31) .
The present study deals with the question of whether noncytotropic antibody also can 18. 18 0. 28 13, 13 0.14 13. 12 BSA regularly induced immediate skin reactions in normal guinea pigs. Evidence of complement dependence derives from the following considerations.
(i) Pretreatment of guinea pigs with CoF to lower complement levels resulted in diminution of preformed complex reactions. By contrast, PCA reactions are not affected by diminished complement levels (7, 8, 22, 24) . Recently, Kay and Austen (22) found small reactions to be elicited in guinea pigs by complexes of guinea pig IgG2 (as well as IgGl). In several guinea pigs pretreated with CoF these small reactions (3 to 6 mm in diameter) were unaffected.
(ii) In a previous report (14) We consider the evidence presented here and in preceding reports to indicate that immediate hypersensitive reactions in the guinea pig can come about through: (i) the reaction of cytotropic antibody with multivalent antigen at cell surfaces, presumably through bridging of antigen by antibody (19) ; (ii) the union of some populations of cytotropic antibody with monovalent antigens at cell surfaces; and (iii) the reaction of noncytotropic antibody with antigen to activate complement, with the presumptive for-mation of anaphylatoxins. There may be additional routes through which reactions occur, e.g., through activation of the sequence of events leading to the formation of kinins.
